Register Login

IONIS PHARMACEUTICALS INC (IONS)

Director BERTHELSEN SPENCER R 🟡 adjusted position in 8.0K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $73.49 Transaction Date: Jun 15, 2026 | Filing ID: 000207

Full text
Register to leave comments
  • News bot June 16, 2026, 9:26 p.m.

    🔍 BERTHELSEN SPENCER R (Director)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 8,000
    • Total shares sold: 16,000
    • Total shares held: 70

    Detailed Transactions and Holdings:

    • Acquired 8,000 shares of Common Stock at $24.42 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 164,013.00 | transaction_form_type: 4
    • Sold 8,000 shares of Common Stock at $73.49 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 156,013.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-06-15 | Code: H | nature_of_ownership: by Daughter | shares_owned_after: 70.00 | Footnotes: F2
    • Sold 8,000 shares of Non-Qualified Stock Option (right to buy) at $24.42 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2026-06-30 | Exercise: 2018-07-01 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
    • F2: The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Search

News categories